Verweise von und zu Vitiligo (overview)
Zurück zum ArtikelVerweise von anderen Artikeln
- Achromia
- Achromia parasitica
- Albinism oculocutaneous tyrosinase-negative
- Allezandrini syndrome
- Autoimmune diseases
- B-clear
- Beta-carotene
- Beta-carotene
- Beta-carotene
- Beer stains
- Camouflage
- Sudden whitening of the hair
- Chloroxylenol
- Chronic lymphocytic thyroiditis
- Chronic mucocutaneous candidiasis
- Cutaneous vaccination reactions
- COVID-19 and skin
- Cowden syndrome
- CVID
- DEFB1 gene
- Dermatitis herpetiformis
- Dihydroxyacetone
- Dupilumab
- Dyschromia, hereditary, familial, spotty
- Excimer laser
- Stain
- Ginkgo
- Ginkgo folium
- Hydroquinone
- Progressive Macular Hypomelanosis
- Idiopathic guttate hypomelanosis
- Selective deficiency of immunoglobulin A
- Immune related adverse events, cutaneous
- Granulomatous interstitial Dermatitis with arthritis
- Janus kinase inhibitors
- Cataract
- Khellin
- Koebner phenomenon
- Kuva therapy
- Lelis syndrome
- Leucoderm
- Vulvar lichen sclerosus
- Lichen sclerosus extragenital
- Mc1r
- Melanotan
- Methoxsalen
- Nevus anaemicus
- Depigmented nevus
- NAT2 gene
- Nlrp
- NLRP1 gene
- NLRP1
- Onchocerciasis
- Pd-1 antibody
- Phototherapy
- Piebaldism
- Pigment shift
- Pinta
- Poliosis
- Polyglandular autoimmune syndromes
- Polyglandular autoimmunsyndrome type 2
- Polypodium leucotomos
- Renbök-Phenomenon
- Ruxolitinib
- Sox10 gene
- Nevus melanocytic halo-nevus
- Tofacitinib
- Tissue-Resident Memory T Cells
- TYK2
- TYR Gene
- Uva-1 therapy
- Uv comb
- Vitiligo generalized
- Vitiligo localized
- Segmental Vitiligo
- Vitiligo universal
- White spot disease
- Wood light
- Gluten-Related Dermatological Disorders
Verweise zu anderen Artikeln
- Alezzandrini syndrome
- Alopecia areata (overview)
- Atopic dermatitis (overview)
- Autoantibodies
- Autoimmune polyglandular syndromes
- Azelaic acid
- Base gel emulsifying hydrophobic (dac)
- Betamethasone valerate
- Camouflage
- Caspasen
- Chronic lymphocytic thyroiditis
- Clobetasol-17-propionate
- Clobetasol propionate cream hydrophilic 0.05% (nrf 11.76.)
- CXCL10
- CXCL9
- Depigmentation
- Dihydroxyacetone
- Dupilumab
- Endotheline
- Excimer laser
- Foxp3 Gene
- Ginkgo biloba extract (inci)
- Ginkgo folium
- Glucocorticosteroids
- Hla system
- Hydroquinone
- Hydrocortisone
- Hydrocortisone cream 0.5-2.0% (w/o)
- Idiopathic guttate hypomelanosis
- Hypomelanosis ito
- IL2RA Gene
- Jak-stat signal path
- Janus kinase inhibitors
- Khellin
- Koebner phenomenon
- Kuva therapy
- Leprosy (overview)
- Leucoderm
- Lichen sclerosus (overview)
- L-phenylalanine
- Lupus erythematosus (overview)
- Med
- Melanoma cutaneous
- Melanotan
- Melanocyte
- Addison's disease
- Mosaic cutaneous
- Nevus anaemicus
- Depigmented nevus
- Nlrp
- Off-label use
- Pemphigus vulgaris
- Piebaldism
- Pimecrolimus
- Pityriasis alba
- Pityriasis versicolor alba
- Poliosis
- Polyglandular autoimmune syndromes
- Polypodium leucotomos
- Prednisolone
- Psoriasis (Übersicht)
- Puva bath therapy
- Puva therapy
- Rituximab
- Ruxolitinib
- Circumscribed scleroderma
- Sox10 gene
- Stratum corneum
- Nevus melanocytic halo-nevus
- Tacrolimus
- Tofacitinib
- Tretinoin
- Triamcinolone acetonide
- Trimethylpsoralen
- Tissue-Resident Memory T Cells
- TYR Gene
- Uv rays
- Vitamins skin changes
- Segmental Vitiligo
- Vogt-koyanagi-harada disease
- Cytokines